Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 5/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31411480 | 1.00 | NPC1 (1.00) | NPC1RAB9AHPGDALDH1A1POLB | |
| SCHEMBL6857852 | 0.94 | NPC1 (0.88) | NPC1RAB9AHPGDALDH1A1POLB | |
| SCHEMBL9503475 | 0.90 | NPC1 (0.81) | NPC1RAB9AHPGDALDH1A1POLB | |
| SCHEMBL3723177 | 0.89 | RAB9A (0.80) | NPC1RAB9AHPGDALDH1A1POLB | |
| SCHEMBL30852954 | 0.89 | RAB9A (0.80) | NPC1RAB9AHPGDALDH1A1POLB | |
| SCHEMBL25356036 | 0.87 | NPC1 (0.77) | NPC1RAB9AHPGDALDH1A1POLB | |
| SCHEMBL8006309 | 0.87 | NPC1 (0.77) | NPC1RAB9AHPGDALDH1A1POLB | |
| SCHEMBL5580334 | 0.87 | NPC1 (0.77) | NPC1RAB9AHPGDALDH1A1POLB | |
| SCHEMBL959541 | 0.87 | NPC1 (0.77) | NPC1RAB9AHPGDALDH1A1POLB | |
| SCHEMBL13070081 | 0.87 | RAB9A (0.75) | NPC1RAB9AHPGDALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3792241-B1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | TAKASAGO PERFUMERY CO LTD (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-11407703-B2 | Method for converting hydroxyl group of alcohol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-08-09 | — | — | US | disclosed |
| EP-3792241-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | Takasago International Corporation (JP) | 2021-03-17 | — | — | EP | disclosed |
| EP-3792241-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | Takasago International Corporation (JP) | 2021-03-17 | — | — | EP | disclosed |
| US-20210047254-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-02-18 | — | — | US | disclosed |
| US-20210047254-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-02-18 | — | — | US | disclosed |
| WO-2019216355-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | 高砂香料工業株式会社 (JP) | 2019-11-14 | — | — | WO | disclosed |
| US-8361922-B2 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | MATERIA, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-20120123133-A1 | ORGANOMETALLIC RUTHENIUM COMPLEXES AND RELATED METHODS FOR THE PREPARATION OF TETRA-SUBSTITUTED AND OTHER HINDERED OLEFINS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2012-05-17 | — | — | US | disclosed |
| US-8008224-B2 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | MATERIA, INC. (US) | 2011-08-30 | — | — | US | disclosed |
| US-20070282148-A1 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2007-12-06 | — | — | US | disclosed |
| US-6737193-B2 | ACTIVE MATERIALS IN THE POSITIVE ELECTRODES OF BATTERIES. NOVEL METHODS FOR PREPARING THE TETRAKETOPIPERAZINE UNIT-CONTAINING COMPOUNDS INCLUDE: (I) REACTING AN OXALYL HALIDE AND AN OXAMIDE, AND ADDING WATER OR AN AQUEOUS ALKALI | IM&T RESEARCH, INC. | 2004-05-18 | — | — | US | disclosed |
| US-20030148188-A1 | Active materials in the positive electrodes of batteries. Novel methods for preparing the tetraketopiperazine unit-containing compounds include: (i) reacting an oxalyl halide and an oxamide, and adding water or an aqueous alkali | IM&T RESEARCH, INC. | 2003-08-07 | — | — | US | disclosed |
| EP-0309619-B1 | RADIATION SENSITIVE ACRYLATE COMPOSITION | Polychrome Corporation (US) | 1993-01-27 | — | — | EP | disclosed |
| EP-0309619-A1 | Radiation sensitive acrylate composition | Polychrome Corporation (US) | 1989-04-05 | — | — | EP | disclosed |
| US-4782005-A | N,N'-diorgano dicarboxamides as oxygen inhibitors in radiation sensitive acrylate compositions | POLYCHROME CORP. (US) | 1988-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120123133-A1 | ORGANOMETALLIC RUTHENIUM COMPLEXES AND RELATED METHODS FOR THE PREPARATION OF TETRA-SUBSTITUTED AND OTHER HINDERED OLEFINS | ORC3, OXER1, CBR3 | NPC1 1521/4885RAB9A 3479/4885HPGD 1250/4885 |
| US-20070282148-A1 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | ORC3, OXER1, CBR3 | NPC1 1521/4885RAB9A 3479/4885HPGD 1250/4885 |
| US-11407703-B2 | Method for converting hydroxyl group of alcohol | ADH1C, CBR1, NAP1L4 | NPC1 1736/4885RAB9A 2827/4885HPGD 915/4885 |
| US-20210047254-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | ADH1C, CBR1, NAP1L4 | NPC1 1736/4885RAB9A 2827/4885HPGD 915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.